UnitedHealth Vs. Novo Nordisk: Which Healthcare Giant Fits Your Portfolio?
1. NVO down 38.59% YTD, highlighting recent volatility. 2. Novo Nordisk shows strong fundamentals with 83.3% gross margin. 3. The company's growth potential attracts investors willing to accept higher risk. 4. NVO's dividend yield of 3.01% appeals to income-focused investors. 5. Investor strategy preference is key: stability vs growth.